Xiaowei Wu, Goodwin Procter LLP Associate, Technology and Life Sciences groups, Strategic Technology Transactions and Licensing practice

Xiaowei (Michelle) Wu

Listen to pronunciation of my name
Spoken Languages
Cantonese Mandarin
Xiaowei (Michelle) Wu
San Francisco
+1 415 733 6062

Xiaowei Wu is an associate in Goodwin’s Technology and Life Sciences groups and a member of the firm’s Strategic Technology Transactions and Licensing practice. Drawing on past experiences as a patent prosecutor, Xiaowei represents companies in the life sciences industries in a variety of matters, including strategic alliances, licensing transactions, and M&A.


Xiaowei’s experience includes the following:

  • SpringWorks Therapeutics, Inc. on its license and collaboration agreement with GSK
  • Palleon Pharmaceuticals on its strategic collaboration agreement with Shanghai Henlius Biotech, Inc.
  • Moderna, Inc. on its strategic partnership with the Australian Federal Government
  • Arrakis Therapeutics on its research collaboration agreement with Amgen
  • Qilu Pharmaceutical, on its exclusive licensing agreement and strategic partnership with Arbutus Biopharma Corporation

Areas of Practice

Professional Experience

Prior to joining Goodwin, Xiaowei was a Patent Associate at another law firm, where she focused her practice on patent prosecution of pharmaceutical, biotech and medical device inventions.




UCLA School of Law

BSBiological Engineering2014

Cornell University

(cum laude)

BSBiological Engineering2014

Shanghai JiaoTong University



  • California